Cargando…
AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo
Sirtuin 2 (SIRT2) is a nicotinamide adenine dinucleotide (NAD( +))-dependent class III histone deacetylase. We have reported that HBx (hepatitis B virus X protein)-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis. However, the potential anti-HBV effect of AGK2, a selective inhibitor...
Autores principales: | Yu, Hai-Bo, Jiang, Hui, Cheng, Sheng-Tao, Hu, Zhong-Wen, Ren, Ji-Hua, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158674/ https://www.ncbi.nlm.nih.gov/pubmed/30275764 http://dx.doi.org/10.7150/ijms.26125 |
Ejemplares similares
-
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2022) -
SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
por: Bhaskar, Ashima, et al.
Publicado: (2023) -
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo
por: Cheng, Sheng-Tao, et al.
Publicado: (2017) -
AGK cutting rules and perturbative QCD
por: Treleani, D
Publicado: (1994) -
Glauber theory, unitarity and the AGK cancellation
por: Bertocchi, L, et al.
Publicado: (1977)